SOX13 dependent PAX8 expression promotes the proliferation of gastric carcinoma cells

References

• Bijlsma MF, Sadanandam A, Tan P, et al. Molecular subtypes in cancers of the gastrointestinal tract. Nat Rev Gastroenterol Hepatol 2017;14:333–342.
   PubMed Web of Science ®Google Scholar
• Balakrishnan M, George R, Sharma A, et al. Changing trends in stomach cancer throughout the world. Curr Gastroenterol Rep. 2017;19:36.
   PubMedGoogle Scholar
• Fitzmaurice C, Akinyemiju TF, Al Lami FH, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2016: a systematic analysis for the global burden of disease study. JAMA Oncol. 2018;4:1553–1568.
   PubMed Web of Science ®Google Scholar
• Ding K, Tan S, Huang X, et al. GSE1 predicts poor survival outcome in gastric cancer patients by SLC7A5 enhancement of tumor growth and metastasis. J Biol Chem. 2018;293:3949–3964.
   PubMed Web of Science ®Google Scholar
• Zheng J, Rutegard M, Santoni G, et al. Prediabetes and diabetes in relation to risk of gastric adenocarcinoma. Br J Cancer. 2019;12:1147-1152.
   Web of Science ®Google Scholar
• Kankeu Fonkoua L, Yee NS. Molecular characterization of gastric carcinoma: therapeutic implications for biomarkers and targets. Biomedicines 2018;6:32.
   PubMed Web of Science ®Google Scholar
• Cidon EU, Ellis SG, Inam Y, et al. Molecular targeted agents for gastric cancer: a step forward towards personalized therapy. Cancers 2013;5:64–91.
   PubMedGoogle Scholar
• Kim TJ, Lee H, Min YW, et al. Diabetic biomarkers and the risk of proximal or distal gastric cancer. J Gastroenterol Hepatol. 2016;31:1705–1710.
   PubMed Web of Science ®Google Scholar
• Chi N, Epstein JA. Getting your Pax straight: Pax proteins in development and disease. Trends Genet. 2002;18:41–47.
   PubMed Web of Science ®Google Scholar
• Mansouri A, Chowdhury K, Gruss P. Follicular cells of the thyroid gland require Pax8 gene function. Nat Genet. 1998;19:87–90.
   PubMed Web of Science ®Google Scholar
• Mittag J, Winterhager E, Bauer K, et al. Congenital hypothyroid female pax8-deficient mice are infertile despite thyroid hormone replacement therapy. Endocrinology. 2007;148:719–725.
   PubMed Web of Science ®Google Scholar
• Li CG, Nyman JE, Braithwaite AW, et al. PAX8 promotes tumor cell growth by transcriptionally regulating E2F1 and stabilizing RB protein. Oncogene. 2011;30:4824–4834.
   PubMed Web of Science ®Google Scholar
• Laury AR, Hornick JL, Perets R, et al. PAX8 reliably distinguishes ovarian serous tumors from malignant mesothelioma. Am J Surg Pathol. 2010;34:627–635.
   PubMed Web of Science ®Google Scholar
• Laury AR, Perets R, Piao H, et al. A comprehensive analysis of PAX8 expression in human epithelial tumors. Am J Surg Pathol. 2011;35:816–826.
   PubMed Web of Science ®Google Scholar
• Nonaka D, Chiriboga L, Soslow RA. Expression of pax8 as a useful marker in distinguishing ovarian carcinomas from mammary carcinomas. Am J Surg Pathol. 2008;32:1566–1571.
   PubMed Web of Science ®Google Scholar
• Melichar HJ, Narayan K, Der SD, et al. Regulation of gammadelta versus alphabeta T lymphocyte differentiation by the transcription factor SOX13. Science (New York, N.Y.). 2007;315:230–233.
   PubMed Web of Science ®Google Scholar
• Marfil V, Moya M, Pierreux CE, et al. Interaction between Hhex and SOX13 modulates Wnt/TCF activity. J Biol Chem. 2010;285:5726–5737.
   PubMed Web of Science ®Google Scholar
• Kido S, Hiraoka Y, Ogawa M, et al. Cloning and characterization of mouse mSox13 cDNA. Gene 1998;208:201–206.
   PubMed Web of Science ®Google Scholar
• Roose J, Korver W, de Boer R, et al. The Sox-13 gene: structure, promoter characterization, and chromosomal localization. Genomics. 1999;57:301–305.
   PubMed Web of Science ®Google Scholar
• He Z, Ruan X, Liu X, et al. FUS/circ_002136/miR-138-5p/SOX13 feedback loop regulates angiogenesis in Glioma. J Exp Clin Cancer Res. 2019;38:65.
   PubMed Web of Science ®Google Scholar
• Bass AJ, Laird PW, Shmulevich I, et al. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014;5:202–209.
   Google Scholar
• Chen YL, Cheng KC, Lai SW, et al. Diabetes and risk of subsequent gastric cancer: a population-based cohort study in Taiwan. Gastric Cancer 2013;16:389–396.
   PubMed Web of Science ®Google Scholar
• Liu Y, Sethi NS, Hinoue T, et al. Comparative molecular analysis of gastrointestinal adenocarcinomas. Cancer Cell. 2018;33:721–735.e728.
   PubMed Web of Science ®Google Scholar
• Duraes C, Almeida GM, Seruca R, et al. Biomarkers for gastric cancer: prognostic, predictive or targets of therapy? Virchows Arch. 2014;464:367–378.
   PubMed Web of Science ®Google Scholar
• Posenato I, Calio A, Segala D, et al. Primary seminal vesicle carcinoma. The usefulness of PAX8 immunohistochemical expression for the differential diagnosis. Human Pathol. 2017;69:123–128.
   PubMed Web of Science ®Google Scholar
• Kar SP, Adler E, Tyrer J, et al. Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci. Br J Cancer. 2017;116:524–535.
   PubMed Web of Science ®Google Scholar
• Koumarianou P, Gomez-Lopez G, Santisteban P. Pax8 controls thyroid follicular polarity through cadherin-16. J Cell Sci. 2017;130:219–231.
   PubMed Web of Science ®Google Scholar
• Hung NA, Eiholzer RA, Kirs S, et al. Telomere profiles and tumor-associated macrophages with different immune signatures affect prognosis in glioblastoma. Mod Pathol. 2016;29:212–226.
   PubMed Web of Science ®Google Scholar
• Sarkar A, Hochedlinger K. The sox family of transcription factors: versatile regulators of stem and progenitor cell fate. Cell Stem Cell 2013;12:15–30.
   PubMed Web of Science ®Google Scholar
• Kamachi Y, Kondoh H. Sox proteins: regulators of cell fate specification and differentiation. Development (Cambridge, England). 2013;140:4129–4144.
   PubMed Web of Science ®Google Scholar
• Ivanov SV, Panaccione A, Nonaka D, et al. Diagnostic SOX10 gene signatures in salivary adenoid cystic and breast basal-like carcinomas. Br J Cancer. 2013;109:444–451.
   PubMed Web of Science ®Google Scholar
• Huang W, Chen Z, Shang X, et al. Sox12, a direct target of FoxQ1, promotes hepatocellular carcinoma metastasis through up-regulating Twist1 and FGFBP1. Hepatology (Baltimore, Md.). 2015;61:1920–1933.
   PubMed Web of Science ®Google Scholar
• Duquet A, Melotti A, Mishra S, et al. A novel genome-wide in vivo screen for metastatic suppressors in human colon cancer identifies the positive WNT-TCF pathway modulators TMED3 and SOX12. EMBO Mol Med. 2014;6:882–901.
   PubMed Web of Science ®Google Scholar